This article is more than 5 years old. Information may no longer be current.

European Commission approves Johnson & Johnson acquisition of Synthes

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The acquisition of Synthes Inc. by Johnson & Johnson has been approved by the European Commission.

The merged entity, the commission noted in an European Commission news release, will still face competition and not limit the availability of alternatives for customers in the markets concerned.

“This was the first time the Commission examined these product markets,” Joaquin Almunia, European Commission vice president in charge of competition policy, stated in the release. “We obtained remedies to ensure that competition will remain strong in these markets, for the ultimate benefit of patients and social security systems.”